PayRx delivers on-demand risk financing solutions and analytics for self-insured employers and health plans to enable greater patient access to high cost advanced therapies.
Contact
Precision medicine is Pharma’s future and it’s here today
Median annual price for new U.S. drugs in 2022 is $257K, with some costing more than $3M
The cost of a single claim can be financially devastating for patients, employers and health plans
The pharmaceutical industry business model is rapidly changing from blockbusters to precision medicines such as cell and gene therapies
As medical science advances, we are witnessing a surge in therapies.
Learn More
The role of analytics in enhancing content management strategies.
Learn More
Key strategies for optimizing your CMS for mobile users.
Learn More
We leverage data science, purpose-built technology and financial engineering to manage the budget-busting impact of high-cost advanced therapies in a unique way that is significantly more affordable while utilizing a value-based pricing model.
PayRx solutions are tailored, easy to implement, and provide greater benefits than traditional approaches
Unpredictable high-cost claims are putting a strain on resources and creating an uneven playing field for payors. For many, the cost of a single event can be financially devastating. Unfortunately, existing healthcare business models and other risk management products are not suited for this growing problem.
PayRx offers solutions that enable all payors to monitor, plan for, and pay for the fast-growing world of life-changing and curative treatments including cell and gene therapies.
Powered by our data science and predictive analytics capabilities, we work with health plans and employers to monitor, plan, and pay for high cost advanced therapies (HCAT)
"The PayRx team took the time to understand me and my team’s needs, then provided a comprehensive solution that exceeded our expectations. It was clear the PayRx team possessed the breadth and depth necessary to understand the challenges we face in healthcare. The insights PayRx provided have significantly accelerated our strategies and, as a result, we are looking to the future for further engagements that will be shared across the greater organization."
Raymond Tarr
Senior Director
US Commercial Diagnostic Strategy Alexion Pharmaceuticals, Inc.
"The recommendation of PayRx to my clients has helped them save money in addition to empowering them with tools and strategies to better navigate the complexities of large healthcare expenses. This proactive approach can lead to better financial flexibility and cash flow for my clients in the short and long term."
Tammeisha D. Smith
Insurance Consultant
Fairview Insurance
PayRx is the industry leader in delivering tailored, on-demand precision risk financing solutions and analytics for self-insured employers and health plans to enable greater patient access to high-cost advanced therapies. We leverage data science, purpose-built technology and financial engineering to manage the cost impact of advanced therapies in a unique way that is significantly more affordable, flexible, and provides greater benefits.
Iaculis id magna arcu nibh magna orci nibh. Lorem donec arcu imperdiet sodales ut non praesent tristique est. Nunc vulputate morbi elit convallis. Consectetur etiam enim dignissim arcu elementum. Arcu orci, malesuada proin ac. Ornare odio morbi laoreet.
Mi at diam nunc lorem aliquam quam parturient. Pharetra quam phasellus lorem eget felis sed a, sem. Consectetur donec scelerisque augue ullamcorper enim maecenas. Nulla a in amet, tristique ullamcorper vel. Nullam id fames faucibus ut.
Vel eget malesuada velit ante nibh mauris lorem diam ultrices. Sit feugiat eu, adipiscing bibendum malesuada. Suspendisse turpis commodo magna at. Vestibulum neque integer enim neque condimentum. Faucibus vel nibh condimentum nibh hac aliquam ac.
Ut cursus in fermentum habitant. Tincidunt ipsum vitae hendrerit tincidunt et. Varius sed quis at nascetur pretium lectus. Arcu quisque egestas tincidunt elementum ultricies blandit. Condimentum mauris, duis in ut ac mattis.
